Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function clinical trials

Explore recruiting myeloid malignancies with moderate or severe hepatic impairment or normal hepatic function clinical trials.

Also recruiting in Europe

Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Study to Evaluate CC-486 in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Cancer Participants

Spain, Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function trials by city

Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Toronto Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Vancouver Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Montreal Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Calgary Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Edmonton Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Ottawa Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Winnipeg Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Quebec City Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Hamilton Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Kitchener Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in London Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Halifax Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in New York Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Los Angeles Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Chicago Myeloid Malignancies With Moderate Or Severe Hepatic Impairment Or Normal Hepatic Function in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease